Definium Therapeutics, Inc.

DFTX

Exchange: Nasdaq
Industry: Medicinal Chemicals & Botanical Products
SEC CIK: 0001813814

SEC filings (opens in a new tab)

In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Definium Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of DFTX: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	152	3	158	+9
Shares	41.5M	5.38M	49.5M	+13.3M (+36.9%)
Value	$299.3M	$38.8M	$281.6M	+$21.1M (+8.1%)

3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Definium Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DFTX in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,664,033	$32.2M	0.00%
Squarepoint Ops LLC	80,121	$455.9K	0.00%
Millennium Management LLC	79,210	$450.7K	0.00%
Alyeska Investment Group, L.P.	66,694	$379.5K	0.00%
XTX Topco Ltd	59,222	$337.0K	0.02%
Oppenheimer & Co Inc	52,381	$298.0K	0.00%
MetLife Investment Management	42,549	$242.1K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	39,508	$224.8K	0.00%
Intech Investment Management LLC	23,473	$133.6K	0.00%
AQR Capital Management LLC	22,773	$129.6K	0.00%
Sanctuary Advisors, LLC	16,002	$121.0K	0.00%
Stoneridge Investment Partners LLC	16,362	$93.0K	0.03%
SG Americas Securities, LLC	16,402	$93.0K	0.00%
Sherbrooke Park Advisers LLC	13,827	$78.7K	0.02%
ProShare Advisors LLC	13,605	$77.4K	0.00%
SEI Investments Co	10,415	$59.3K	0.00%
Wealth Enhancement Advisory Services, LLC	10,200	$58.0K	0.00%
Jaffetilchin Investment Partners, LLC	2,389	$13.6K	0.00%
Russell Investments Group, Ltd.	812	$4.62K	0.00%
Venturi Wealth Management, LLC	721	$4.10K	0.00%
Steward Partners Investment Advisory, LLC	500	$2.85K	0.00%
GAMMA Investing LLC	183	$1.04K	0.00%
Tower View Investment Management & Research LLC	100	$569	0.00%
Cornerstone Planning Group LLC	77	$497	0.00%
Capital Performance Advisors LLP	80	$455	0.00%
Sterling Capital Management LLC	74	$421	0.00%
Fifth Third Bancorp	59	$336	0.00%
True Wealth Design, LLC	19	$109	0.00%
NBT Bank N A	6	$34	0.00%
Strategic Investment Solutions, Inc.	6	$34	0.00%

Sold out (21)

Institutions that held Definium Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DFTX in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Artal Group S.A.	1,007,875	$7.27M
Alpine Global Management, LLC	68,176	$491.5K
Group One Trading, L.P.	44,365	$319.9K
Cubist Systematic Strategies, LLC	35,508	$256.0K
Bank of Montreal	33,133	$240.2K
Man Group plc	32,062	$231.2K
Walleye Capital LLC	18,487	$133.3K
Bridgewealth Advisory Group, LLC	10,000	$72.1K
Thrivent Financial for Lutherans	10,027	$72.0K
Simplex Trading, LLC	8,841	$63.0K
Aquatic Capital Management LLC	6,600	$47.6K
Quantbot Technologies LP	1,577	$11.4K
Opal Wealth Advisors, LLC	1,101	$7.94K
Wolff Wiese Magana LLC	206	$1.49K
Banque Cantonale Vaudoise	66	$1.00K
New Millennium Group LLC	100	$721
Signature Resources Capital Management, LLC	53	$382
American Capital Advisory, LLC	33	$121
Castleview Partners, LLC	16	$115
ZRC Wealth Management, LLC	15	$109
PrairieView Partners, LLC	4	$0

Not filed for Q3 2024 yet (3)

Institutions that held Definium Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DFTX in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	5,384,030	$38.8M
Emfo, LLC	300	$2.16K
JJJ Advisors Inc.	10	$73